Latest update:
Tuesday, May 10, 2016 - 09:43
5 February 2015
Sopharma AD notifies that for January 2015 the Company recorded a decrease of sales revenues of 43% compared to the same month of 2014, including 11% increase of domestic sales and 61% decrease of export sales.
The volatility of the RUB caused us to undertake actions to adjust the prices for our main export market - Russia, which prevented us from exporting during the period. Our forecast is that this slow down in the beginning of the year will be compensated already in the first quarter.